We comply with the
HONcode standard for trustworthy health information:
verify here

The European LeukemiaNet is a publicly funded research network of excellence. Goal is cure of leukemia by integration of European leukemia research and spread of excellence. The website delivers information for physicians, patients (e.g. patient organisations in Europe), ongoing clinical trials and further information about the disease. You can get information about the European LeukemiaNet in various european languages. The European LeukemiaNet is funded by the 6th Framework Program of the European Community.

News

Information Letter no.12

Right in time for the annual symposium, we are pleased to present the 12th Information Letter of the European LeukemiaNet. In this issue: results from the PROMYSE APL registry, new therapies and the role of TP53 alterations in CLL, ELTS-score for CML, the new EU-regulation on clinical trials, MDS-RIGHT, and many more.

New Score: EUTOS long-term survival (ELTS) score for CML

The new ELTS score allows for the prognosis of long-term survival in adult CML patients. Determine the prognostic risk group using the free online calculator.

MDS Pocket Card 2014

Diagnosis and treatment of primary myelodysplastic syndromes (MDS) in adults. Recommendations from the European LeukemiaNet

Events
We 2017/09/13 - Sa 2017/09/16 Society of Hematologic Oncology 2017 Annual Meeting
Mo 2017/10/30 - We 2017/11/01 XXVIII IACRLRD Symposium International Association for Comparative Research on Leukemia and Related Diseases
Su 2018/03/25 - We 2018/03/28 7th New Directions in Leukaemia Research (NDLR) meeting

The European LeukemiaNet

194 Participating Centers in 39 Countries (1000 Researchers and Associates) are cooperating in the European Leukemia Net. The objective is to integrate the 108 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their 105 interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia related research and health care (data updated July 2013).

Keywords: leukemia, leukaemia, leukämie, leucemie, leucémie, leucemia, leukemi, leukemie, lösemi, Лейкоз, λευχαιμία, سرطان الدّم, 白血病, leukemija, leukemije, leŭkemio, biaŁacka,ש"עסרטן הדם, לויקמיה